China Bozza to Raise Up to HK$51.5 Million via Non-Underwritten Rights Issue

China Bozza Development Holdings Limited ( (HK:1069) ) has shared an update.

China Bozza Development Holdings Limited plans to raise up to approximately HK$51.5 million through a rights issue on the basis of two rights shares for every one existing share at a subscription price of HK$0.25 per rights share. The offer will be made on a non-underwritten basis only to qualifying shareholders, with unsubscribed rights shares to be placed to independent investors on a best-effort basis and any unplaced portion not issued.

After estimated expenses, net proceeds of about HK$50 million are earmarked mainly for business expansion and working capital. Around 44% will fund the acquisition of ginseng plantation land and related marketing, approximately 36% will be invested in the medical aesthetics industry, and the remaining 20% will replenish general working capital, reflecting a push into health and wellness segments and support for ongoing operations.

The most recent analyst rating on (HK:1069) stock is a Hold with a HK$0.29 price target. To see the full list of analyst forecasts on China Bozza Development Holdings Limited stock, see the HK:1069 Stock Forecast page.

More about China Bozza Development Holdings Limited

China Bozza Development Holdings Limited is a Hong Kong-listed company incorporated in the Cayman Islands. The group is expanding into ginseng plantation and is also targeting investments in the medical aesthetics industry, indicating a strategic focus on health-related and consumer wellness sectors alongside its existing operations.

Average Trading Volume: 294,094

Technical Sentiment Signal: Sell

Current Market Cap: HK$31.91M

For a thorough assessment of 1069 stock, go to TipRanks’ Stock Analysis page.